The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists

Yonkers, Kimberly A.; Wisner, Katherine L.; Stewart, Donna E.; Oberlander, Tim F.; Dell, Diana L.; Stotland, Nada; Ramin, Susan; Chaudron, Linda; Lockwood, Charles

doi:10.1016/j.genhosppsych.2009.04.003

« Previous Next »General Hospital Psychiatry
Volume 31, Issue 5 , Pages 403-413, September 2009

The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists☆☆☆

Kimberly A. Yonkers, M.D.
- Department of Psychiatry, Epidemiology and Public Health, Yale School of Medicine, New Haven, CT 06510, USA
- Department of Obstetrics and Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06510, USA
- Corresponding author. Department of Psychiatry, Epidemiology and Public Health, Yale School of Medicine, New Haven, CT, USA. Fax: +1 203 764 6766.
Katherine L. Wisner, M.D., MS.
- Department of Psychiatry, Obstetrics and Gynecology, Women's Behavioral, HealthCARE, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
- Department of Reproductive Sciences, Epidemiology and Women's Studies, Women's Behavioral, HealthCARE, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
Donna E. Stewart, M.D., FRCPC
- Departments of Psychiatry, Obstetrics and Gynecology, Family and Community Medicine, Medicine, Surgery and Anesthesia, University Health Network Women's Health Program, University of Toronto, Toronto, Ontario, Canada M5G 2C4
Tim F. Oberlander, M.D., FRCPC
- Department of Pediatrics, University of British Columbia, Human Early Experience Unit, Centre for Community Child Health Research, Child and Family Research Institute, Vancouver, British Columbia, Canada V6 3V4
Diana L. Dell, M.D., FACOG
- Duke University Medical Center, DUMC Box 3263, Durham, NC 27710, USA
Nada Stotland, M.D., M.P.H.
- Department of Psychiatry and Obstetrics, Rush Medical College Chicago, IL 60637, USA
- Department of Gynecology, Rush Medical College Chicago, IL 60637, USA
Susan Ramin, M.D., FACOG
- The University of Texas Health Science Center at Houston, Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Maternal–Fetal Medicine, Houston, TX 77030, USA
Linda Chaudron, M.D., MS.
- Department of Psychiatry, Pediatrics and Obstetrics and Gynecology, University of Rochester, Rochester, NY 14642, USA
Charles Lockwood, M.D., FACOG
- Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, PO Box 208063, New Haven, CT 06520-8063, USA

Received 10 February 2009; accepted 9 April 2009. published online 25 August 2009.

To access this article, please choose from the options below

☆ Dr. Yonkers has received a research grant from Eli Lilly this past year. She has received study drug from Pfizer for a National Institute of Mental Health trial. Dr. Stewart serves on the Advisory Boards of Wyeth and Eli Lilly and Boehringer Ingelheim. Dr. Dell has received research grants from Pfizer has consulted to Bayer Schering Pharma AG and Berlex and is on the Speaker's Bureau for Berlex, GlaxoSmithKline, Pfizer and Wyeth. Dr. Wisner serves on the Speaker's Board of Glaxo Smith Klein. Dr. Oberlander; Dr. Ramin; and Drs. Stotland, Chaudron, and Lockwood have no conflicts to disclose.

☆☆ This article is being published concurrently in the September 2009 issue of Obstetrics & Gynecology.

PII: S0163-8343(09)00061-9

doi:10.1016/j.genhosppsych.2009.04.003

« Previous Next »General Hospital Psychiatry
Volume 31, Issue 5 , Pages 403-413, September 2009

Access this article on SciVerse ScienceDirect